Skip to main content

Advertisement

Log in

Species Distribution and Antifungal Susceptibility Profile of Oral Candida Isolates from HIV-infected Patients in the Antiretroviral Therapy Era

  • Published:
Mycopathologia Aims and scope Submit manuscript

Abstract

In this study, we investigated the yeasts colonization of genus Candida, including C. dubliniensis, isolated of HIV-infected patients oral cavities and we accessed in vitro susceptibility pattern of the Candida isolates to four antifungal agents. Out of 99 patients investigated, 62 (62.6%) were colonized with yeasts. C. albicans was the prevailing species (50%). C. dubliniensis isolates were not recovered in our study. We verified that 8.1% of the yeasts isolated were resistant to fluconazole, 8.1% to itraconazole and 3.2% to voriconazole. The isolates demonstrated very low voriconazole MICs, in which 79% (49/62) presented values of 0.015 μg/ml. All Candida isolates were susceptible to amphotericin B. The results reported here showed that although C. albicans continues to be present in one-half of oral Candida carriage of HIV-infected patients, Candida non-albicans species are increasing among these patients. Besides, the findings of resistant isolates endorse the role of antifungal susceptibility testing whenever antifungal treatment with azoles is planned.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

DMSO:

Dimetyl sulfoxide

HDT:

Hospital de Doenças Tropicais

HIV:

Human Immunodeficiency Virus

MICs:

Minimal Inhibitory Concentrations

MOPS:

Morpholinepropanesulfonic acid

NCCLS:

National Committee for Clinical Laboratory Standards

OPC:

Oropharyngeal candidiasis

SDA:

Sabouraud Dextrose Agar

References

  1. WR Kirkpatrick SG Revankar RK Mcatee JL Lopez-Ribot AW Fothergill DL McCarthy SE Sanches RA Cantu MG Rinaldi TF Patterson (1998) ArticleTitleDetection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar Candida screening and susceptibility testing of isolates J Clin Microbiol 36 3007–3012 Occurrence Handle9738058 Occurrence Handle1:STN:280:DyaK1cvhtFCiug%3D%3D

    PubMed  CAS  Google Scholar 

  2. DJ Sullivan TJ Westerneng KA Haynes DE Bennett D Coleman (1995) ArticleTitle Candida dubliniensis sp. Nov: Phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals Microbiology 141 1507–1521 Occurrence Handle7551019 Occurrence Handle1:CAS:528:DyaK2MXntFGgur0%3D

    PubMed  CAS  Google Scholar 

  3. R Fotedar SSA Al-Hedaithy (2005) ArticleTitleComparison of phospholipase and proteinase activity in Candida albicans and C. dubliniensis Mycoses 48 62–67 Occurrence Handle15679669 Occurrence Handle1:CAS:528:DC%2BD2MXisVCjsr8%3D Occurrence Handle10.1111/j.1439-0507.2004.01057.x

    Article  PubMed  CAS  Google Scholar 

  4. SR Schorling HC Kortinga M Froschb FA Mühlsclegel (2000) ArticleTitleThe role of Candida dubliniensis in oral candidiasis in human immunodeficiency virus-infected individual Crit Rev Microbiol 26 59–68 Occurrence Handle10782340 Occurrence Handle1:STN:280:DC%2BD3c3ksVWqtQ%3D%3D Occurrence Handle10.1080/10408410091154183

    Article  PubMed  CAS  Google Scholar 

  5. I Dolapaci A Tekeli JS Gocmen D Aysev H Guriz (2002) ArticleTitleInvestigation of Candida dubliniensis in Candida spp –positive hemocultures APMIS 110 391–395 Occurrence Handle10.1034/j.1600-0463.2002.100504.x

    Article  Google Scholar 

  6. P Nenoff U Oswald UF Haustein (1999) ArticleTitleIn vitro susceptibility of yeasts for fluconazole and itraconazole. Evaluation of a microdilution test Mycoses 42 629–639 Occurrence Handle10680439 Occurrence Handle1:CAS:528:DC%2BD3cXpt1KqtQ%3D%3D Occurrence Handle10.1046/j.1439-0507.1999.00510.x

    Article  PubMed  CAS  Google Scholar 

  7. AL Colombo D Da Matta LP Almeida ParticleDe R Rosas (2002) ArticleTitleFluconazole susceptibility of Brazilian Candida isolates assessed by a disk diffusion method J Infect Dis 6 118–123 Occurrence Handle10.1016/S1201-9712(02)90072-X

    Article  Google Scholar 

  8. M Sojakova D Liptajova M Borovsky J Subik (2004) ArticleTitleFluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia Mycopathologia 157 163–169 Occurrence Handle15119851 Occurrence Handle1:CAS:528:DC%2BD2cXitlGksrY%3D Occurrence Handle10.1023/B:MYCO.0000020594.35357.b0

    Article  PubMed  CAS  Google Scholar 

  9. CP Kurtzman JW Fell (1998) The Yeasts: a taxonomic study EditionNumber4 Elsevier Amsterdam 77–100

    Google Scholar 

  10. A Tekeli E Koyuncu I Dolapaci GS Guven GO Sahin O Uzin (2005) ArticleTitleDetection of Candida dubliniensis in oropharyngeal samples of Turkish HIV-positive patients Mycoses 48 197–201 Occurrence Handle15842337 Occurrence Handle1:STN:280:DC%2BD2M3gvFeqsA%3D%3D Occurrence Handle10.1111/j.1439-0507.2005.01125.x

    Article  PubMed  CAS  Google Scholar 

  11. NCCLS-National Committee for Clinical Laboratory Standards 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard. Document M27-A2. Villanova, PA, v. 17, n. 9

  12. MH Nguyen CJ Chancy VL Yu YC Yu AJ Morris DR Snydman (1998) ArticleTitleDo in vitro susceptibility data predict the microbiological response to Amphotericin B? Results of a prospective study of patients with Candida fungemia J Infect Dis 177 425–430 Occurrence Handle9466531 Occurrence Handle1:CAS:528:DyaK1cXhtVaht7g%3D Occurrence Handle10.1086/514193

    Article  PubMed  CAS  Google Scholar 

  13. MA Pfaller DJ Diekman RN Jones HS Sader AC Fluit RJ Hollis (2001) ArticleTitleInternational surveillance of bloodstream infections due to Candida species, frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program J Clin Microbiol 39 3254–3259 Occurrence Handle11526159 Occurrence Handle1:STN:280:DC%2BD3Mvot12lug%3D%3D Occurrence Handle10.1128/JCM.39.9.3254-3259.2001

    Article  PubMed  CAS  Google Scholar 

  14. PL Fidel SuffixJr JA Vazquez JD Sobel (1999) ArticleTitle Candida glabrata: review of epidemiology, pathogenesis and clinical disease with comparison to C. albicans Rev Clin Microbiol 12 80–96

    Google Scholar 

  15. NR Melo H Taguchi J Jorge RJ Pedro OP Almeida K Fukushinma K Nishimura M Muyaji (2004) ArticleTitleOral Candida from Brazilian Human Immunodeficiency virus-infected patients in the highly active antiretroviral therapy era Mem Inst Oswaldo Cruz 99 425–431 Occurrence Handle15322634 Occurrence Handle1:CAS:528:DC%2BD2cXmsVantL0%3D Occurrence Handle10.1590/S0074-02762004000400014

    Article  PubMed  CAS  Google Scholar 

  16. F Drondra M Alonso-Sanz F Laguna F Chavez JV Martinez-Suarez JL Rodríguez-Tudella A Gonzalez-Lopez E Valencia (1996) ArticleTitleMixed oropharyngeal candidiasis due to Candida albicans and non albicans Candida strains in HIV-infected patients Eur J Clin Microbiol Infect Dis 19 446–452 Occurrence Handle10.1007/BF01691310

    Article  Google Scholar 

  17. SW Redding WR Kirkpatrick O Dib AW Fothergill MG Rinaldi TF Patterson (2000) ArticleTitleThe epidemiology of non albicans Candida in oropharyngeal candidiasis in HIV-patients Spec Care Dentist 20 78–81

    Google Scholar 

  18. PG Fotos JW Hellstein (1992) ArticleTitleCandida and candidosis Epidemiology, diagnosis and therapeutic management Dent Clin North Am 36 857–858 Occurrence Handle1:STN:280:DyaK3s%2Fht1WnsA%3D%3D

    CAS  Google Scholar 

  19. DJ Sullivan DC Coleman (1998) ArticleTitle Candida dubliniensis: characteristics and identification J Clin Microbiol 36 329–334 Occurrence Handle9466736 Occurrence Handle1:CAS:528:DyaK1cXnsFCqsA%3D%3D

    PubMed  CAS  Google Scholar 

  20. JFGM Meis M Ruhnke BED Pauw FC Odds W Siegert PE Verweij (1999) ArticleTitle Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation Emerg. Infect Dis 5 150–153 Occurrence Handle10081684 Occurrence Handle1:STN:280:DyaK1M7otFGhtw%3D%3D Occurrence Handle10.3201/eid0501.990119

    Article  PubMed  CAS  Google Scholar 

  21. ME Brandt LH Harrison M Pass NA Sofair S Huje R Li CJ Morrison DW Warnock RA Hajjeh (2000) ArticleTitle Candida dubliniensis fungemia: the first four cases in North America Emerg Infect Dis 6 46–49 Occurrence Handle10653569 Occurrence Handle1:STN:280:DC%2BD3c7hvFGjsA%3D%3D

    PubMed  CAS  Google Scholar 

  22. AM Willis WA Coulter DJ Sullivan DC Coleman JR Hayes PM Bell PJ Lamey (2000) ArticleTitleIsolation of Candida dubliniensis from insulin diabetes mellitus patients J Oral Pathol Med 29 86–90 Occurrence Handle10718404 Occurrence Handle1:STN:280:DC%2BD3c7otFegsA%3D%3D Occurrence Handle10.1034/j.1600-0714.2000.290206.x

    Article  PubMed  CAS  Google Scholar 

  23. TJ Müller MA Jabra-Riszk A Baqui JI Kelley VI Meeks WG Merz WA Falkler (1999) ArticleTitleOral Candida dubliniensis as a clinically important species in HIV-seropositive patients in the United States Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88 573–580 Occurrence Handle10.1016/S1079-2104(99)70088-0

    Article  Google Scholar 

  24. PLS Mariano EP Milan DA Matta Particleda AL Colombo (2003) ArticleTitle Candida dubliniensis identification in Brazil yeast stock collection Mem Inst Oswaldo Cruz 98 533–538 Occurrence Handle10.1590/S0074-02762003000400020

    Article  Google Scholar 

  25. P Godoy IN Tiraboshi LC Severo B Bustamante B Calvo LP Almeida DA Matta AL Colombo (2003) ArticleTitleSpecies distribution and antifungal susceptibility profile of Candida spp bloodstream isolates from Latin American Hospitals Mem Inst Oswaldo Cruz 98 401–405 Occurrence Handle12886424 Occurrence Handle1:CAS:528:DC%2BD3sXls1Cmu78%3D Occurrence Handle10.1590/S0074-02762003000300020

    Article  PubMed  CAS  Google Scholar 

  26. MA Ribeiro R Dietze CR Paula DA Matta Particleda AL Colombo (2000) ArticleTitleSusceptibility profile of vaginal yeast isolates from Brazil Mycopathologia 151 5–10 Occurrence Handle10.1023/A:1010909504071

    Article  Google Scholar 

  27. MA Pfaller SA Messer RJ Hollis (1994) ArticleTitleStrain delineation and antifungal susceptibilities of epidemiologically related and unrelated isolates of Candida lusitaniae Diagn Microbiol Infect Dis 20 127–133 Occurrence Handle7874879 Occurrence Handle1:CAS:528:DyaK2MXjsF2is7s%3D Occurrence Handle10.1016/0732-8893(94)90106-6

    Article  PubMed  CAS  Google Scholar 

  28. TL Hardfield MB Smith RE Winn MG Rinaldi C Guerra (1997) ArticleTitleMycoses caused by Candida lusitaniae Rev Infect Dis 9 1006–1012

    Google Scholar 

  29. MA Pfaller DJ Diekema SA Messer L Boyken RJ Hollis RN Jones (2003) ArticleTitleInternational Fungal Surveillance Participant Group. In vitro activities of voriconazole, posaconazole and four licensed systemic antifungal agents against Candida species infrequently isolated from blood J Clin Microbiol 41 78–83 Occurrence Handle12517829 Occurrence Handle1:CAS:528:DC%2BD3sXhtFGmtbo%3D Occurrence Handle10.1128/JCM.41.1.78-83.2003

    Article  PubMed  CAS  Google Scholar 

  30. A Favel A Michel-Nguyen A Datry S Charllier F Leclerc C Chastin K Fallague P Regli (2004) ArticleTitleSusceptibility of clinical isolates of Candida lusitaniae to five systemic antifungal agents J Antimicrobial Chemother 53 526–529 Occurrence Handle1:CAS:528:DC%2BD2cXhvFSrtrg%3D Occurrence Handle10.1093/jac/dkh106

    Article  CAS  Google Scholar 

  31. MD Martins M Lozano-Chiu JH Rex (1997) ArticleTitlePoint prevalence of carriage of fluconazole in the oropharyngeal of HIV infected patients Clin Infect Dis 25 843–846 Occurrence Handle9356799 Occurrence Handle1:STN:280:DyaK1c%2FhvFKntQ%3D%3D

    PubMed  CAS  Google Scholar 

  32. AB Lattif U Banerjee R Prasad A Biswas N Wig N Sharma A Haque N Gupta NZ Baquer G Mukhopadhyay (2004) ArticleTitleSusceptibility pattern and molecular type of species-specific Candida in oropharyngeal lesions of Indian Human Immunodeficiency Virus-positive patients J Clin Microbiol 42 1260–1262 Occurrence Handle15004088 Occurrence Handle10.1128/JCM.42.3.1260-1262.2004

    Article  PubMed  Google Scholar 

  33. A Wildfener HP Seidl I Paule A Haberreiter (1998) ArticleTitle In vitro evaluation of voriconazole against clinical isolates of yeast, moulds and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin B and griseofulvin Mycoses 41 309–319 Occurrence Handle10.1111/j.1439-0507.1998.tb00344.x

    Article  Google Scholar 

  34. JA Sabo SM Abdel-Rahman (2000) ArticleTitleVoriconazole a new triazole antifungal Ann Pharmacother 34 1032–1043 Occurrence Handle10981251 Occurrence Handle1:CAS:528:DC%2BD3cXmslSrt74%3D Occurrence Handle10.1345/aph.19237

    Article  PubMed  CAS  Google Scholar 

  35. M Cuenca-Estrela E Mellado TMD Guerra Monzón JLR Tudela (2000) ArticleTitleSusceptibility of fluconazole-resistant clinical isolates of Candida spp. to echinocandin LY303366, itraconazol and amphotericin B J Antimicrob Chemother 46 475–477 Occurrence Handle10.1093/jac/46.3.475

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maria do Rosário Rodrigues Silva.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Costa, C.R., de Lemos, J.A., Passos, X.S. et al. Species Distribution and Antifungal Susceptibility Profile of Oral Candida Isolates from HIV-infected Patients in the Antiretroviral Therapy Era. Mycopathologia 162, 45–50 (2006). https://doi.org/10.1007/s11046-006-0032-y

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11046-006-0032-y

Keywords

Navigation